Trial Profile
Naloxone hydrochloride gastro-resistant sustained release capsules as a treatment for functional constipation: a randomised, double-blind controlled trial in secondary care.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 02 Feb 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 10 May 2011 Results presented at Digestive Disease Week 2011.
- 05 Aug 2010 New trial record